CTi Biopharma Corp Buy Hold or Sell Recommendation
| CTICDelisted Stock | USD 9.09 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding CTi Biopharma Corp is 'Not Rated'. Macroaxis provides CTi Biopharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CTIC positions.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. In addition, we conduct extensive research on individual companies such as CTi and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards CTi Biopharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
CTi |
Execute CTi Biopharma Buy or Sell Advice
The CTi recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on CTi Biopharma Corp. Macroaxis does not own or have any residual interests in CTi Biopharma Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute CTi Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
CTi Biopharma Trading Alerts and Improvement Suggestions
| CTi Biopharma Corp is not yet fully synchronised with the market data | |
| CTi Biopharma Corp has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 53.95 M. Net Loss for the year was (92.99 M) with profit before overhead, payroll, taxes, and interest of 50.43 M. | |
| CTi Biopharma Corp currently holds about 81.64 M in cash with (81.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64. | |
| Over 83.0% of the company shares are held by institutions such as insurance companies |
CTi Biopharma current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CTi analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CTi analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
CTi Biopharma Returns Distribution Density
The distribution of CTi Biopharma's historical returns is an attempt to chart the uncertainty of CTi Biopharma's future price movements. The chart of the probability distribution of CTi Biopharma daily returns describes the distribution of returns around its average expected value. We use CTi Biopharma Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of CTi Biopharma returns is essential to provide solid investment advice for CTi Biopharma.
| Mean Return | 1.53 | Value At Risk | -3.58 | Potential Upside | 5.30 | Standard Deviation | 10.80 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of CTi Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Reed Tuckson of 80000 shares of CTi Biopharma subject to Rule 16b-3 [view details]
CTi Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as CTi . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About CTi Biopharma Buy or Sell Advice
When is the right time to buy or sell CTi Biopharma Corp? Buying financial instruments such as CTi Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having CTi Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Defense Thematic Idea Now
Defense
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Defense theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Defense Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in CTi Stock
If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |